|
Volumn 104, Issue 21, 2001, Pages 2588-2594
|
In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone
|
Author keywords
Diabetes; Ischemia; Myocardial infarction; PPAR ; Rosiglitazone
|
Indexed keywords
CD11B ANTIGEN;
CD18 ANTIGEN;
INTERCELLULAR ADHESION MOLECULE 1;
L SELECTIN;
MONOCYTE CHEMOTACTIC PROTEIN 1;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
ROSIGLITAZONE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
CORONARY ARTERY LIGATION;
DOSE RESPONSE;
DRUG MECHANISM;
HEART INFARCTION;
HEART INFARCTION SIZE;
HEART MUSCLE CONTRACTILITY;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE REPERFUSION;
HEART PROTECTION;
LEFT ANTERIOR DESCENDING CORONARY ARTERY;
MACROPHAGE;
MALE;
NEUTROPHIL;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RAT;
REPERFUSION INJURY;
SYSTOLIC BLOOD PRESSURE;
|
EID: 0035923566
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/hc4601.099403 Document Type: Article |
Times cited : (298)
|
References (29)
|